Patients with tumours exhibiting low Ki67 expression in association with 1 to 100% cyclin D1-positive nuclei (high) were associated with a considerably lower risk of recurrence (P < 0.001) (Figure 5b) compared with the other subgroups. This evidence concerns the gene MKI67 and neoplasm.